Fri 19'th Oct 2018
Tandem Diabetes Care Stock Analysis
Technical stock analysis for Fri 19'th Oct 2018
|Shorts||1.22% ( 2018-09-28 )|
Tandem Diabetes Care fell by -6.40% in the last day from $38.59 to $36.12 and has now fallen 3 days in a row. The price has risen in 6 of the last 10 days , but is still down by -1.98% for this period. Volume has increased in the last day by 0.46 million shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 1.94 million shares bought and sold for approximately $69.99 million.
Tandem Diabetes Care lies in the lower part of a very wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $34.12 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 27.89% during the next 3 months and, with 90% probability hold a price between $43.63 and $71.80 at the end of this period.
There are few to none technical positive signals at the moment. Tandem Diabetes Care holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $37.20 and $41.28. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Wednesday October 17, 2018, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Relative Strength Index (RSI)
RSI14 is 44 and the stock is currently not being overbought or oversold
Support & Resistance
Tandem Diabetes Care finds support from accumulated volume at $35.64.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $3.99 between high and low, or 11.24%. For the last week, the stock has had a daily average volatility of 7.96%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
The Tandem Diabetes Care stock holds several negative signals and despite the positive trend we believe Tandem Diabetes Care will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.Click for Top 5 Sell Candidates
|TNDM $36.12 $-2.47(-6.40%)|
TNDM is down $2.47 today, but where's it headed in November?
|Zacks Investment Research is releasing its prediction for TNDM based on the 1-3 month system that more than doubles the S&P 500.
Click here – the TNDM analysis is free »